Explorance Doubles European Higher-Education Client Base
Explorance, the leading provider of Learning Journey Analytics (LJA) solutions doubled its European client base in the past year. With the opening of new European offices, Explorance will be able to better partner with its growing European clients.
Improving the quality and relevance of teaching and learning in the European higher education market is the centre of the Bologna Process. The Yerevan Communiqué strengthened the call for better visibility of this policy area. According to the EUA Trends 2018 survey, 90% of the institutions use student feedback surveys to assess and enhance the quality of teaching. As the Bologna Process entices institutions to embrace a digitally-enabled approach, more institutions move toward the strategic use of digital tools to measure learning and teaching improvements.
“Before implementing Blue, we were using a dozen or so traditional questionnaires, combined with a few digital surveys. The wide range of individual solutions made it impossible to take full benefit of course evaluations,” says Mustapha Ali El-Ahmad, Senior Evaluation Consultant and Analyst at the Aarhus University. He adds, “Blue combines all these different questionnaires into one single solution, cleaning the data from the LMS & SIS, and automating the data analysis, while accommodating to different schools’ requirements.” Explorance’s Blue is built to support various feedback processes including course evaluations, competency development assessment, midterm reviews, applicant feedback, alumni perception analysis, student satisfaction, organisational surveys, and 360 degree reviews.
“The surge in demand for Explorance software and services in Europe indicates a growing need for proven online teaching and learning evaluation tools and increased trust in the Blue solution,” commented Ian Haugh, General Manager of the European offices. The new European office is located in Amsterdam and coordinates local activities across Europe and the UK. Local professional services are offered across Europe and customer service is provided 24/7 in multiple languages.
Blue surveys and evaluation solutions are fully localised with English, French, Spanish, German, Dutch, Swedish, Norwegian, Danish, Icelandic, Italian, Russian and Portuguese support. To support student mobility, Blue allows multiple languages to be used in one implementation at the same time. For an evaluation of your organisation’s needs, contact Explorance for a demonstration.
Explorance is a Learning Journey Analytics (LJA) provider that supports organisations in making the right decisions using fact-based feedback data. Through its Blue suite of products, organisations can assess needs, expectations, competencies, and monitor improvement over time.
Founded in 2003, Explorance is a privately held corporation headquartered in Montreal, Canada with business units in America, APAC, Europe, and the MENA region. As of 2014, Explorance has been ranked top employer by the Great Places to Work Institute®. Explorance's clients span a wide variety of learning organisations including academia, consulting firms, government institutions, and corporations. Learn more about Explorance.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor Wins Patent Litigation against Everlight in Germany and Is Awarded Statutory Litigation Costs11.12.2018 14:00 | Pressemelding
Seoul Semiconductor Co., Ltd. (KOSDAQ:046890) (“Seoul”), a leading global innovator of LED products and technology, announced that it won a patent litigation against Everlight Electronics Co., Ltd. (“Everlight”) in Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005233/en/ Seoul Semiconductor's Headquarters in Korea (Photo: Business Wire) The patent involved in this litigation relates to an LED package structure for thermal dissipation. Everlight purchased this patent from a U.S. company in 2017, and subsequently brought a patent lawsuit against Seoul in the Manheim Court of Germany. In December 2018, however, the Manheim Court ruled in favor of Seoul and ordered that Everlight, as the losing party, should bear the statutory costs of the court proceeding. In the United Kingdom, Seoul had already won a patent litigation against Everlight earlier this year. At that time, the UK Patent Court also ordered that Ever
Zodiac Appoints Derek Harrar CEO11.12.2018 14:00 | Pressemelding
Zodiac, a software vendor serving video service providers, announced today it has appointed Derek Harrar to serve as the Company’s Chief Executive Officer, effective immediately. Mr. Harrar has been on Zodiac’s board of directors since 2015, having being appointed at the time of One Equity Partners’ investment in the Company. “Derek’s considerable video industry operational and technology experience, rigorous execution and creativity are exactly what Zodiac needs for its next stage of growth, complementing the team we have put in place since our original investment,” said Andrew Dunn, Managing Director at One Equity Partners. Zodiac’s historic focus has been engineering software solutions for major video service providers in North America. This software experience, spanning a broad range of video technology permutations, is unique in the video distribution industry. More recently, Zodiac productized its carrier-grade cloud and client platform, enabling rapid and flexible deployment at
Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. with Druggability Technologies11.12.2018 13:00 | Pressemelding
Quotient Sciences, a leading drug development services organization, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration today to utilize Quotient’s integrated Translational Pharmaceutics® platform to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib using proprietary super-API compositions developed by DRGT. This will be Quotient’s first Translational Pharmaceutics program delivered from its U.S. operating facilities. Within the program of work, DRGT is accessing Quotient’s unique Translational Pharmaceutics platform. This involves the development of amorphous spray-dried formulations and GMP clinical trial manufacturing in Philadelphia followed by clinical dosing and taste assessment at Quotient’s clinical pharmacology unit in Miami. The program is fully adaptive, which will enable DRGT to optimize the drug product in response to emerging clinical data. Quotient will then seamlessly scale up the selected
The Brightline Initiative Announces Strategic Partnership with NetEase11.12.2018 13:00 | Pressemelding
The Brightline Initiative announced today that NetEase (网易) joined its coalition as first founding member from the Asia region to help address the growing challenges of strategy implementation leveraging on insight and learnings from Chinese technology companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005409/en/ Brightline Initiative Announces Strategic Partnership with NetEase (Photo: Business Wire) Launched in early 2017, the Brightline™ Initiative is a coalition, led by the Project Management Institute together with leading global organizations, dedicated to helping executives bridge the expensive and unproductive gap between strategy design and delivery. Brightline focuses its work on three key areas: Thought and Practice Leadership, Networking and Capability Building. NetEase Hangzhou Research Institute Chief Executive Chen Gang said, “Historically NetEase has been paying close attention on strategy design
AMRA Receives U.S. FDA Clearance for AMRA® Profiler, a Magnetic Resonance Diagnostic Software Application Enabling Non-Invasive Evaluation of Body Composition11.12.2018 11:28 | Pressemelding
AMRA Medical (“AMRA”), the international leader in body composition analysis, announced today that it has received FDA clearance for AMRA® Profiler, now available for use in a clinical setting in the US. AMRA® Profiler is indicated for use as a magnetic resonance (MR) diagnostic device for non-invasive fat and muscle evaluation that enables the generation, display and review of MR-based body composition measurements. AMRA is the first in the world to transform MR-images from a 6-minute whole-body MRI scan into 3D-volumetric fat and muscle measurements, enabling outstanding accuracy and precision when assessing volume and distribution of fat and muscles, as well as metabolic status. “We are delighted with the FDA’s decision. The challenges facing healthcare systems across the world are well-documented. Cost constraints, together with societal issues such as obesity and an aging population, are putting hospitals and private clinics under increasing pressure,” stated Eric Converse, CEO of
Acuris Risk Intelligence Celebrates 350 Direct Customers and Wins Compliance Awards11.12.2018 11:00 | Pressemelding
Acuris Risk Intelligence, a trusted and independent provider of data intelligence for Anti-Money Laundering, Third Party Risk and Cyber Security professionals, today announces that it now serves 350 direct customers worldwide, helping them to mitigate risk and effectively comply with regulations. This significant milestone nearly doubles its direct client base compared to this time last year and is only two months since the relaunch of the brand, formerly known as C6. Whilst the business has been successful since its inception in 2004 in selling its data via major channel partners, this is a noteworthy milestone as it reflects the success of focusing on direct customer outreach. The business continues to work with some of the biggest compliance platforms in the world as an integrated provider. Acuris Risk Intelligence has also won FinTech/RegTech Rising Star and Best Financial Crime Intelligence Data at The Compliance Register Platinum Awards 2018 as well as executing a successful expa